NeoChord Inc., a venture-backed medical device company focused on minimally-invasive mitral valve repair, yesterday announced that its mitral valve repair system will be featured in the scientific program at the upcoming 26th Annual Meeting of the European Association for Cardio-Thoracic Surgery (EACTS).
OneMedPlace announced today that its “OneMedForum 2011” business development and finance conference for emerging healthcare and life science companies will be held January 11-13, 2011, in San Francisco at the Sir Francis Drake Hotel.
Approximately 250,000 new diagnoses of MR are made each year, but only about 50,000 patients undergo surgery to fix the problem.
Traditional heart surgery to repair faulty valves entails opening the chest cavity and temporarily stopping the heart. The surgery’s invasiveness and high risk factor excludes […]
An infusion of capital will help NeoChord go the distance. Previously, the company had raised $1.76 million from angel investors in a convertible debt offering. […]
This interview with John Seaberg, CEO of NeoChord, is the first of many filmed earlier this month at the OMP Finance Forum. NeoChord aims to […]
Copyright © 2025 | WordPress Theme by MH Themes